CannaPharmaRX, Inc. Stock

CPMD

US13765D1090

Healthcare Facilities & Services

Market Closed - OTC Markets 20:42:26 11/09/2026 +03			5-day change	1st Jan Change
0.002000 ^USD	-16.67%		-16.67%	-61.54%

08-18	CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-20	CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Valuation : CannaPharmaRX, Inc.

Market Cap	1.34M 1.16M 1.1M 994K 1.87M 128M 1.87M 13.03M 5.01M 65.35M 5.05M 4.94M 206M	P/E 2024	-0.51x	P/E 2025	-0.31x
Enterprise Value	21.99M 18.95M 17.94M 16.26M 30.51M 2.1B 30.66M 213M 81.95M 1.07B 82.6M 80.78M 3.38B	EV / Sales 2024	23,622,884x	EV / Sales 2025	17,663,843x
Free-Float	92.65%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : CannaPharmaRX, Inc.

08-18	CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-20	CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-01	CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-31	CannaPharmaRX, Inc. Auditor Raises 'Going Concern' Doubt	CI
01-13	Cannapharmarx, Inc. Announces Resignation of Director Rick Orman, Effective January 8, 2026	CI
11-15	CannaPharmaRX, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
19/08/25	Cannapharmarx, Inc. Plans to Open Its Sixth Growing Room in September	CI
19/08/25	Cannapharmarx, Inc. Announces Series of Strategic Developments	CI
19/08/25	Cannapharmarx, Inc. Announces Revenue Guidance for Third Quarter 2025	CI
14/08/25	CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
16/05/25	CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
10/04/25	CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
10/04/25	CannaPharmaRX, Inc. Auditor Raises 'Going Concern' Doubt	CI

More news

Press Releases : CannaPharmaRX, Inc.

06/05/25	CannapharmaRx Continues into New European Market with First Shipment Completed to Germany	AQ
23/06/23	CANNAPHARMARX, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
22/12/22	Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond	NE
21/12/22	CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million	AQ
22/11/22	CANNAPHARMARX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ

More press releases

Managers and Directors : CannaPharmaRX, Inc.

Manager	Title	Age	Since
Constantine Nkafu CEO	Chief Executive Officer	50	07/09/2024
Oliver Foeste DFI	Director of Finance/CFO	50	13/10/2023

Director	Title	Age	Since
Dominick Colvin BRD	Director/Board Member	57	01/04/2018
Anthony Panek BRD	Director/Board Member	41	25/08/2023
Constantine Nkafu BRD	Director/Board Member	50	31/03/2025

More insiders

CannaPharmaRX Inc. is a Canada-based cannabis company focused on producing medical cannabis and craft products. The Company operates from its facility in Cremona, Alberta, Canada and is able to produce over 6,000 kilograms per year. The Company is focused on the acquisition, development, and operation of cannabis cultivation facilities in Canada. The Company produces and sells dried cannabis flower, which is packaged for sale as dried flower and trim shake. It sells dried flowers for medicinal purposes. The Company's products include unique genetics, craft products, medical cannabis, its brands and licenses. Craft cannabis, also known as craft marijuana, is cannabis that is produced on a small scale by artisanal or independent producers.

Employees

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
11/09/26	$0.002000	-16.67%	771,000
04/09/26	$0.002400	0.00%	1,100
03/09/26	$0.002400	0.00%	71,000

Delayed Quote OTC Markets

More quotes

1 day	-16.67%
1 week	-16.67%
Current month	-16.67%
3 months	-23.08%
6 months	-59.18%
Current year	-61.54%

1 week	0		0
1 month	0		0
Current year	0		0.01
1 year	0		0.01
3 years	0		0.03
5 years	0		0.05
10 years	0		4

Date	Insider	Type	% Market Cap.	Importance
12/30/25 A	Amir David Tal	Other	0%	-
12/30/25 A	Amir David Tal	Other	0%	-
12/30/25 A	Amir David Tal	Other	0%	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CANNAPHARMARX, INC.	-16.67%	-16.67%	-33.33%	+199,900.00%	1.34M
VILLAGE FARMS INTERNATIONAL, INC.	+0.70%	-1.37%	+15.20%	+171.70%	352M
ORGANIGRAM GLOBAL INC.	-2.04%	-9.43%	-37.12%	-43.08%	146M
CANNARA BIOTECH INC.	+1.79%	0.00%	+15.70%	+103.06%	142M
ASCEND WELLNESS HOLDINGS, INC.	+12.09%	+9.68%	-26.09%	-60.16%	104M
INTERCURE LTD.	-1.41%	-2.89%	-39.83%	-48.06%	63.09M
IANTHUS CAPITAL HOLDINGS, INC.	0.00%	+100.00%	0.00%	-71.43%	50.28M
Average	-0.79%	+11.67%	-15.07%	+28,564.58%	122.63M
Weighted average by Cap.	+1.57%	+4.80%	-3.62%	+378.26%

	2024	2025
Net sales	0.82 0.71 0.67 0.61 1.14 78.35 1.14 7.95 3.06 39.86 3.08 3.01 125.96	1.36 1.17 1.11 1.01 1.89 130.13 1.9 13.2 5.08 66.21 5.12 5 209.21
Net income	-9.91M -8.53M -8.08M -7.32M -13.74M -946M -13.81M -95.98M -36.91M -481M -37.2M -36.39M -1.52B	-11.13M -9.59M -9.08M -8.23M -15.44M -1.06B -15.52M -108M -41.48M -541M -41.81M -40.89M -1.71B
Net Debt	14.06M 12.11M 11.47M 10.4M 19.5M 1.34B 19.6M 136M 52.38M 683M 52.8M 51.64M 2.16B	20.65M 17.79M 16.85M 15.27M 28.64M 1.97B 28.79M 200M 76.94M 1B 77.55M 75.85M 3.17B

CannaPharmaRX, Inc. Stock

Stocks

CPMD

US13765D1090

Healthcare Facilities & Services

Valuation : CannaPharmaRX, Inc.

Chart: CannaPharmaRX, Inc.

Latest news : CannaPharmaRX, Inc.

Press Releases : CannaPharmaRX, Inc.

Quotes and Performance

Price Extremes

Managers and Directors : CannaPharmaRX, Inc.

Latest insider transactions

Medical Farming

Financials

Company Profile

Quotes